TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

CompletedOBSERVATIONAL
Enrollment

1,441

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

August 6, 2024

Study Completion Date

September 30, 2024

Conditions
Respiratory Tract InfectionsUrinary Tract InfectionsIntra-Abdominal InfectionsSkin and Soft Tissue InfectionSuspected Meningitis/Encephalitis or Any Other InfectionSepsis
Interventions
DIAGNOSTIC_TEST

TriVerity

Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection and sputum/ BAL sample collection

Trial Locations (26)

15260

University of Pittsburgh, Pittsburgh

17822

Geisinger Health, Danville

20010

Medstar Health Research Institute, Washington D.C.

21209

Johns Hopkins Hospital, Baltimore

29425

Medical University of South Carolina, Charleston

30303

Emory University, Atlanta

32209

University of Florida (UF) - Jacksonville, Jacksonville

36617

University of South Alabama, Mobile

37232

Vanderbilt University Medical Center, Nashville

40536

University of Kentucky, Lexington

44195

Cleveland Clinic, Cleveland

48202

Henry Ford Hospital, Detroit

52242

University of Iowa, Iowa City

53226

Medical College of Wisconsin, Milwaukee

55805

Essentia Institute of Rural Health, Duluth

55905

Mayo Clinic, Rochester

63110

Washington University, St Louis

73104

Oklahoma University Health, Oklahoma City

77030

Baylor College of Medicine, Houston

79905

Texas Tech University Health Sciences Center - El Paso, El Paso

90033

University of Southern California, Los Angeles

95817

University of California Davis Medical Center, Sacramento

02215

Beth Israel Deaconess Medical Center, Boston

01199

Baystate Medical Center, Springfield

07042

Hackensack Meridian Health, Montclair

Unknown

ATTIKON University Hospital, Athens

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inflammatix

INDUSTRY